A Study to Learn More About How Well 8 Milligram Aflibercept Works and How Safe it is in Chinese Participants With Diabetic Macular Edema
Clinical trial NCT06422507 · COMPLETED
Trial details
- NCT number
- NCT06422507
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-29
- Primary completion
- 2025-12-29
- Enrollment
- 333
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.